These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31319613)

  • 21. Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach.
    Jung HS; Han J; Shi H; Koo S; Singh H; Kim HJ; Sessler JL; Lee JY; Kim JH; Kim JS
    J Am Chem Soc; 2017 Jun; 139(22):7595-7602. PubMed ID: 28459562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers.
    Williams KJ; Gieling RG
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
    Robertson N; Potter C; Harris AL
    Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells.
    Sarnella A; Ferrara Y; Albanese S; Omodei D; Cerchia L; De Simone G; Supuran CT; Zannetti A
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.
    Cook MT; Liang Y; Besch-Williford C; Hyder SM
    Breast Cancer (Dove Med Press); 2017; 9():9-19. PubMed ID: 28096694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
    Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
    Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting carbonic anhydrase IX improves the anti-cancer efficacy of mTOR inhibitors.
    Faes S; Planche A; Uldry E; Santoro T; Pythoud C; Stehle JC; Horlbeck J; Letovanec I; Riggi N; Datta D; Demartines N; Dormond O
    Oncotarget; 2016 Jun; 7(24):36666-36680. PubMed ID: 27153561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coordinated Regulation of Metabolic Transporters and Migration/Invasion by Carbonic Anhydrase IX.
    McDonald PC; Swayampakula M; Dedhar S
    Metabolites; 2018 Mar; 8(1):. PubMed ID: 29517989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells.
    McDonald PC; Dedhar S
    Subcell Biochem; 2014; 75():255-69. PubMed ID: 24146383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX.
    Xu P; Zhang Y; Ge F; Zhang F; He X; Gao X
    Front Oncol; 2021; 11():637252. PubMed ID: 34249682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the Role of Hypoxia-Inducible Carbonic Anhydrase IX (CAIX) in Circulating Tumor Cells (CTCs) of Breast Cancer.
    Twomey JD; Zhang B
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
    van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
    Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CAIX Regulates Invadopodia Formation through Both a pH-Dependent Mechanism and Interplay with Actin Regulatory Proteins.
    Debreova M; Csaderova L; Burikova M; Lukacikova L; Kajanova I; Sedlakova O; Kery M; Kopacek J; Zatovicova M; Bizik J; Pastorekova S; Svastova E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer.
    Jin MS; Lee H; Park IA; Chung YR; Im SA; Lee KH; Moon HG; Han W; Kim K; Kim TY; Noh DY; Ryu HS
    Virchows Arch; 2016 Aug; 469(2):183-90. PubMed ID: 27184798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipocalin 2 prevents oral cancer metastasis through carbonic anhydrase IX inhibition and is associated with favourable prognosis.
    Lin CW; Yang WE; Lee WJ; Hua KT; Hsieh FK; Hsiao M; Chen CC; Chow JM; Chen MK; Yang SF; Chien MH
    Carcinogenesis; 2016 Jul; 37(7):712-722. PubMed ID: 27207653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aza-BODIPY based carbonic anhydrase IX: Strategy to overcome hypoxia limitation in photodynamic therapy.
    Pewklang T; Chansaenpak K; Bakar SN; Lai RY; Kue CS; Kamkaew A
    Front Chem; 2022; 10():1015883. PubMed ID: 36405312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
    Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting carbonic anhydrase IX with small organic ligands.
    Wichert M; Krall N
    Curr Opin Chem Biol; 2015 Jun; 26():48-54. PubMed ID: 25721398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer.
    Neumeister VM; Sullivan CA; Lindner R; Lezon-Geyda K; Li J; Zavada J; Martel M; Glazer PM; Tuck DP; Rimm DL; Harris L
    Breast Cancer Res Treat; 2012 Nov; 136(1):67-75. PubMed ID: 22976806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.